While there are many opportunities to use microalgae as antimicrobial agents, little has
been done to develop them beyond the characterization phase to the biotechnology phase …

Nearly two hundred microalgal strains (174 Chlorophyta and 23 Cyanobacteria) were
screened against some bacteria, filamentous fungi and yeasts using a disc-diffusion type …

Numerous biochemical compounds are synthesized by algae in a wide variety of
ecosystems. To date, more than 18,000 new bioactive compounds have been isolated from …

Microalgae exhibit a huge genetic diversity; they may indeed appear as individual cells,
colonies or extended filaments. Ubiquitously distributed throughout the biosphere, they can …

Increased proliferation of bacterial resistance to antibiotics is a critical issue that has
increased the demand for novel antibacterial compounds. Antibacterial activities have been …

Microbial infections are one of the prominent causes of health problems, physical disabilities
and mortalities around the world. There is a widespread belief that green medicines are …

Microalgae and cyanobacteria are photoautotrophic microorganisms, present in almost all
ecosystems around the world. Due to their rich biodiversity and possibly high growth …

In recent decades, marine microorganisms have become known for their ability to produce a
wide variety of secondary bioactive metabolites. Several compounds have been isolated …

Microalgae and cyanobacteria have sparked a lot of interest due to their potential in various
industries like biorefineries, biopharmaceuticals, food supplements, nutraceuticals, and …

In the last decades, an increasing attention has been directed toward the possibilities of
growing algae commercially. This interest has been partially due to the fact that some strains …